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Edited by Alain Beck, New York: Springer, 2013, Vol. 988, 355 pages. ISBN: 978-1-62703-326-8
Glycosylation Engineering of Biophar-
maceuticals: Methods and Protocols
Edited by Alain Beck is a comprehen-
sive, step by step instruction manual for
creating and characterizing therapeutic
proteins, in particular, monoclonal anti-
bodies, with carbohydrate modifications.
The book, published under the aegis of
Springer Protocols series, is divided into 4
sections:
• “Glycoengineering of therapeutic
proteins” focusing on how to pro-
duce tailored glycosylated versions of
monoclonal antibodies as therapeutic
proteins.
• “Glycoanalytics” focusing on analyti-
cal characterization involving methods
like mass spectroscopy and chromato-
graphic separation to identify and pro-
file signatures of glycosylated proteins.
• “Glycoprotein complex characteriza-
tion” focusing on analytical methods for
epitope mapping and Ag-Ab complexes.
• “PK/PD assays for therapeutic antibod-
ies” focusing on assays to measure spe-
cific pharmacological potency readouts
for glycosylated therapeutics.
It is obvious from the content that
the book is intended as a reference
manual of protocols and best practices
for the practicing bench scientist. The
authors do a marvelous job of covering
a wide variety of tools and techniques
and bringing them together in one vol-
ume. Whereas books have been previously
written on the chemistry of glycosyla-
tion (see Alexei Demchenko’s Handbook
of Chemical Glycosylation, focusing on
synthesis and structures of glycosylated
derivatives), and the biology of protein
glycosylation (see Rosalyn Bill’s Protein
Glycosylation, focusing on purification,
function and kinetics of selected glycosy-
lation enzymes and in vivo function of
glycosylated proteins), this volume is the
first comprehensive collection of HOW to
synthesize glycoproteins in the lab.
The organization of chapters in the
book has a logical flow with an introduc-
tion that sets the reader up for appreciating
the salient issues involved in the protocol
described subsequently. These sections are
followed by those on data interpretation
and artifacts and finally ending in notes
and references to primary literature.
• The introduction goes into the WHY of
the experiments i.e., the rationale for
the experimental protocol but assumes
knowledge of the scientific background.
Consequently, the uninitiated reader
might have to refer to a standard text-
book or review papers to grasp finer
detail. This is not a shortcoming of the
book because the intended audience is
expected to be reasonably well versed
with the basics of glycoprotein biol-
ogy and chemistry before attempting
to work in the lab. I believe that these
descriptions should have schematic out-
lines of experimental strategy, ample
information that set up an experimen-
talists’ mind to carry out the experiment
thoroughly and interpret the results,
positive or negative, with appropri-
ate scientific rigor. In this context, I
found the description of scientific ratio-
nale most comprehensively described in
Chapters 4, 5, 6, and 18. Other chapters
had them too but these chapters stand-
out in the clarity and representation of
the experimental rationale and putting
it in context of the theoretical knowl-
edge in the glycol-biology space.
• The protocols go into the HOW of the
experiments. They are very well orga-
nized and comprehensive. They pro-
vide a step by step recipe for carrying
out an experiment or analytical pro-
cess. Thought I have not tested any of
the protocols in the lab, I do believe
by reading through them that they are
quite comprehensive. At the end of the
day, if a reasonably capable experimen-
talist is able to carry out an experiment
for the first time using a protocol, it
is considered to be a comprehensive
one. Through that filter, I believe that
someone wanting to benchmark a pro-
cess or establish one for the first time
will benefit from the descriptions con-
tained in the protocol. They go deeper
than what can be gleaned away from
the Materials and Methods sections of
published papers and hopefully incor-
porate some of the best practices that
came though experience of the authors
of the respective chapters.
• The section on data interpretation is
not explicitly outlined in every chap-
ter, but sometimes incorporated into
the experimental strategy section (e.g.,
Chapter 5) or sometimes follows the
description of the experimental proto-
cols (e.g. Chapters 7, 9, and 19). An
experimentalist who is attempting a
new technique for the first time will find
this section particularly illuminating
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because s/he can form a mental picture
of what the data will look like and how
can it be interpreted.
• The notes section is essentially a cheat-
sheet, a compilation of experimental
best practices. I believe this is an
absolutely critical aspect of every chap-
ter because an experimentalist with-
out years of experience (as the authors
have) will not necessarily understand
the “feel” of the experiment without
these best practices.
• Finally, each chapter has a section on
primary literature. One shortcoming in
this is lack of “loop-back” to the proto-
col or the notes section. What I would
have much appreciated is some form
of cross-reference to the notes or the
scientific rational/introduction section.
In that way, a proficient experimentalist
could have gone back to the original ref-
erence in a targeted manner, if required.
What was particularly pertinent to me
was the focus on monoclonal antibodies
as substrate for glycosylation, thereby
creating methods that are of therapeu-
tic relevance. Glycoengineered MAb’s
have gained increasing prominence in
the world of targeted drugs, particularly
against cancer. Defined glycosylation
patterns boost the pharmacological prop-
erties of MAb’s. It has already yielded
Mogamulizumab for refractory Adult
T-Cell Leukemia/Lymphoma indication
(Anti-CCR4, approved in Japan, commer-
cial under trade name Poteligio) and there
are at least 16 other glycol-engineered
MAb’s in the clinical pipeline including
the most advanced Obinutuzumab pro-
gram from Roche (Phase-III, Anti-CD20
humanized IgG1). Disease indications for
which these Glyco-engineered MAb’s are
being evaluated mostly include hema-
tological malignancy and solid tumor
indications in the oncology space, but also
disease with immune-modulatory target
mechanisms (e.g., Asthma).
This collection of protocols will find
an audience with experimentalists in the
biopharmaceutical industry as well as var-
ious academic labs. Contract research
organizations, particularly those focus-
ing on analytical services or synthesis
services will also benefit from the proto-
cols described. Finally, the readers should
always realize that they are reading in a
book form, protocols that are constantly
evolving. New techniques, materials and
methods are being published every day
that improve on or radically change the
way we do things. Compilations on pro-
tocols are therefore, by definition, to be
constantly updated. The publishers and
authors can therefore provide a back-up
online resource as an adjunct to the desk-
top volume for practitioners to use. In
absence of that, the shelf-life of a book of
protocols is short. I hope the publishers
and authors are cognizant of this. Overall,
I would strongly recommend this book
and advice the authors and publishers to
aspire to become the “Maniatis manual”
of Antibody Glycobiology.
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